The Top Five Most Viewed Content at Diagnostic Imaging in July 2023

News
Slideshow
Conferences|SNMMI

Catch up on the most viewed content at Diagnostic imaging in July 2023.

Our top five content in July ranged from a breakdown of new research about the rise of non-physician practitioner (NPP) imaging interpretation to our coverage of the SNMMI 2023 conference, including research about the use of an emerging PET radiotracer to detect coronary artery disease in obese patients and the promise of ultra-high resolution (UHR) brain PET. Review the slideshow below to see this month's top content.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 2
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, Part 1
Addressing Cybersecurity Issues in Radiology
Related Content
Predicting Diabetes on CT Scans: What New Research Reveals with Pancreatic Imaging Biomarkers

Predicting Diabetes on CT Scans: What New Research Reveals with Pancreatic Imaging Biomarkers

Jeff Hall
March 25th 2025
Article

Attenuation-based biomarkers on computed tomography (CT) scans demonstrated a 93 percent interclass correlation coefficient (ICC) agreement across three pancreatic segmentation algorithms for predicting diabetes, according to a study involving over 9,700 patients.

The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET

The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET

Jeff Hall
March 18th 2025
Podcast

In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.

PSMA PET Prep Product Gozellix Garners FDA Approval

PSMA PET Prep Product Gozellix Garners FDA Approval

Jeff Hall
March 21st 2025
Article

Indicated for use in cases involving suspected metastasis with PCa or suspected PCa recurrence due to elevated PSA level, Gozellix reportedly has a longer shelf life than other gallium-based PET imaging products.

The Reading Room: Potential fMRI Alternative -- fPACT

The Reading Room: Potential fMRI Alternative -- fPACT

Whitney J. Palmer
June 23rd 2021
Podcast

Drs. Charles Liu and Jonathan Russin discuss the benefits and potential of fPACT, the alternative to functional MRI.

AI Denoising Bolsters Ultra-Low-Dose CT Detection of Pneumonia Findings in Immunocompromised Adults

AI Denoising Bolsters Ultra-Low-Dose CT Detection of Pneumonia Findings in Immunocompromised Adults

Jeff Hall
March 14th 2025
Article

For immunocompromised individuals, denoised ultra-low-dose CT offers similar detail as normal-dose CT scans for pneumonia detection, according to a recent study.

New Meta-Analysis Assesses Impact of 68Ga-FAPI PET CT/MRI for Ovarian Cancer

New Meta-Analysis Assesses Impact of 68Ga-FAPI PET CT/MRI for Ovarian Cancer

Jeff Hall
March 13th 2025
Article

Researchers found that use of 68Ga-FAPI PET was associated with pooled sensitivity of 90 percent for ovarian cancer, according to a recent meta-analysis.

© 2025 MJH Life Sciences

All rights reserved.